Skip to main content

Service navigation

  • Contact
  • Become a member
  • Member portal
Menu
Home

Hoofdnavigatie

  • Domains
    • Human Health
    • Planetary Health
  • Members
  • Benefits
  • Funding
    • Project Call 2026.2
    • Intercluster cSBO call
    • Find a partner
  • Roadmaps
  • What's new
    • News
    • Events
    • Jobs
    • Science for Health
    • HealthTech Investor Summit
  • About Biovia
    • Mission & vision
    • Boards
    • Team

Discover the latest news in health innovation

Category

  • Medical biotech (1)
  • Member news (7)

Tags

  • (-) Merger & Acquisition (69)
  • Research (300)
  • Collaborations (210)
  • Finance / Funding (204)
  • Clinical / Field trials (196)
  • People (195)
  • Innovation (192)
  • Patients (133)
  • Infrastructure (56)
  • Software / IT / AI (46)
  • Other (15)
  • Regulatory (14)

Year

  • (-) 2026 (2)
  • 2025 (13)
  • (-) 2024 (5)
  • 2023 (10)
  • 2022 (21)
  • 2021 (7)
  • 2020 (11)
InnoSer International now offers sponsors a single, flexible partner across the full preclinical path, from early feasibility testing through GLP-compliant, submission-ready data. The addition of Vivo Science’s expertise reflects InnoSer’s ongoing strategy of expanding across Europe through organic growth paired with the selective acquisition of specialized CROs.
04 Aug 2026

InnoSer Adds Regulatory Immunotoxicology Expertise with Acquisition of GLP-certified German CRO Vivo Science.

Multiple categories
Fund+ quote
07 Apr 2026

Fund+ Portfolio Company Tubulis Announces its Acquisition by Gilead

Member news
04 Dec 2024

QbD Group announces acquisition of SciencePharma, strengthening global regulatory and quality expertise

Member news
05 Sep 2024

P95 Acquires Assign DMB, Expanding Data Management and Biostatistics Services

Member news
04 Jul 2024

Anacura acquires OHMX.bio, adding multi-omics for drug discovery and diagnostics to its services

Member news
15 Feb 2024

Mithra sells shares in Mayne Pharma

Member news
01 Feb 2024

Galapagos completes transaction to transfer Jyseleca® business to Alfasigma

Member news

More info?

Ellen Telleir

Communications Project Manager
linkedin.com/in/ellentelleir/
ellen.telleir@biovia.be
Contact us
Ellen

Stay tuned about the latest updates in health innovation

Subscribe to our newsletter and receive regular updates.

Subscribe now

Contact us

  • info@biovia.be
  • BE1016 786 167
Home

Follow us

  • Youtube
  • LinkedIn

Voet

  • © 2026 | FBM vzw
  • Disclaimer
  • Privacy statement
  • Cookie policy
  • Domains
    • Human Health
    • Planetary Health
  • Members
  • Benefits
  • Funding
    • Project Call 2026.2
    • Intercluster cSBO call
    • Find a partner
  • Roadmaps
  • What's new
    • News
    • Events
    • Jobs
    • Science for Health
    • HealthTech Investor Summit
  • About Biovia
    • Mission & vision
    • Boards
    • Team
  • Contact
  • Become a member
  • Member portal